| oral surgery | The branch of dentistry concerned with the diagnosis and surgical and adjunctive treatment of diseases, injuries, and deformities of the oral and maxillofacial region. (05 Mar 2000) |
|---|---|
| oral surgical procedures | Procedures used to treat disease, injuries, and defects of the oral and maxillofacial region. (12 Dec 1998) |
| oral surgical procedures, preprosthetic | Surgery necessary for a denture to rest on a firm base, free from marked osseous protuberances or undercuts, and devoid of interfering muscle attachments, excess mucoperiosteum, hyperplasias, and fibrous or papillary growths. (12 Dec 1998) |
| oral teeth | <dentistry> Your centrals, laterals, and cuspids. These are the teeth in the front of your mouth. (08 Jan 1998) |
| oral ulcer | A loss of mucous substance of the mouth showing local excavation of the surface, resulting from the sloughing of inflammatory necrotic tissue. It is the result of a variety of causes, e.g., denture irritation, aphthous stomatitis (stomatitis, aphthous), noma, necrotizing gingivitis (gingivitis, necrotizing, ulcerative), toothbrushing, and various irritants. (12 Dec 1998) |
| oral vestibule | That part of the mouth bounded anteriorly and laterally by the lips and the cheeks, posteriorly and medially by the teeth and/or gums, and above and below by the reflections of the mucosa from the lips and cheeks to the gums. Synonym: vestibulum oris, buccal cavity, vestibule of mouth. (05 Mar 2000) |
| essential amino acids | Alpha-amino acids nutritionally required by an organism and which must be supplied in its diet (i.e., cannot be synthesised by the organism) either as free amino acid or in proteins. (05 Mar 2000) |
| tuberculosis, oral | Tuberculosis of the mouth, tongue, and salivary glands. (12 Dec 1998) |
| excitatory amino acids | Endogenous amino acids released by neurons as excitatory neurotransmitters. Glutamic acid is the most common excitatory neurotransmitter in the brain. Aspartic acid has been regarded as an excitatory transmitter for many years, but the extent of its role as a transmitter is unclear. (12 Dec 1998) |
| florid oral papillomatosis | Diffuse involvement of the lips and oral mucosa with benign squamous papillomas; microscopically, it resembles verrucous carcinoma, but is not invasive or localised to a specific area of the oral mucosa. (05 Mar 2000) |
| 2-amino-2-deoxy-D-galactose | <chemical> Chemical name: D-Galactose, 2-amino-2-deoxy- (12 Dec 1998) |
| 2-amino-5-phosphonovalerate | <chemical> A potent and specific antagonist of nmda receptors (receptors, nmda) in the d-enantiomeric form. The l form is inactive at nmda receptors but may affect the ap4 (2-amino-4-phosphonobutyrate; apb) excitatory amino acid receptors. Pharmacological action: excitatory amino acid antagonists. Chemical name: Norvaline, 5-phosphono- (12 Dec 1998) |
| (3-(arginyl)amino-4-(4-nitrophenyl)butyryl)-leucyl-prolyl-threonine | Pharmacological action: neurotransmitters Synonym: 2-afb(p-no2)-proctolin, (afb(p-no2)(2))-proctolin (26 Jun 1999) |
| 8-amino-7-oxononanoate synthase | <enzyme> Chemical name: 7-keto-8-aminopelargonic acid synthetase Registry number: EC 2.3.1.47 Synonym: 7-kap synthetase, 8-amino-7-oxopelargonate synthase, 7-oxo-8-aminononanoate synthase, biof gene product (26 Jun 1999) |
| leukoedema, oral | A disorder of the buccal mucosa resembling early leukoplakia, characterised by the presence of filmy opalescence of the mucosa in the early stages to a whitish gray cast with a coarsely wrinkled surface in the later stages, associated with intracellular oedema of the spinous or malpighian layer. (12 Dec 1998) |